Markus Stana

7PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Formal methods for software
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 30, 2025
MLR and dMLR Predict Locoregional Control and Progression-Free Survival in Unresectable NSCLC Stage III Patients: Results from the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR).

Alexandra Hochreiter, Markus Stana, Marisa Klebermass

|Dec 24, 2025
Durvalumab Is Associated with Prolonged Progression-Free Survival, While Concomitant Chemoradiotherapy May Improve Both Locoregional and Local Control in Elderly Patients with Unresectable NSCLC Stage III: Subanalysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR).

Franz Zehentmayr, Josef Karner, Markus Stana

|Aug 28, 2025
Delta Changes in [<sup>18</sup>F]FDG PET/CT Parameters Can Prognosticate Clinical Outcomes in Recurrent NSCLC Patients Who Have Undergone Reirradiation-Chemoimmunotherapy.

Brane Grambozov, Nazanin Zamani-Siahkali, Markus Stana

|Feb 13, 2025
Cone-Beam CT Segmentation for Intraoperative Electron Radiotherapy Based on U-Net Variants with Transformer and Extended LSTM Approaches.

Sara Vockner, Matthias Mattke, Ivan M Messner

|Feb 13, 2025
Immunotherapy Improves Clinical Outcome in Kirsten Rat Sarcoma Virus-Mutated Patients with Unresectable Non-Small Cell Lung Cancer Stage III: A Subcohort Analysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR).

Elvis Ruznic, Marisa Klebermass, Barbara Zellinger

|Apr 13, 2023
Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DL<sub>CO</sub> Correlate with Radiation Dosimetry and Pneumonitis Rate.

Markus Stana, Brane Grambozov, Josef Karner

Pageof 2

Frequent Collaborators

7 joint publications

Elvis Ruznic

7 joint publications

Franz Zehentmayr

3 joint publications

Brane Grambozov

2 joint publications

Ayurzana Purevdorj